Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: Results from a collaborative multicenter study in Italy

Breast Cancer Research and Treatment

Volumn 134, Issue 1, 2012, Pages 411-418

  Ottini, Laura ^a   Silvestri, Valentina ^a   Rizzolo, Piera ^a   Falchetti, Mario ^a   Zanna, Ines ^b   Saieva, Calogero ^b   Masala, Giovanna ^b   Bianchi, Simonetta ^c   Manoukian, Siranoush ^d   Barile, Monica ^e   Peterlongo, Paolo ^d,f   Varesco, Liliana ^g   Tommasi, Stefania ^h   Russo, Antonio ⁱ   Giannini, Giuseppe ^a   Cortesi, Laura ^j   Viel, Alessandra ^k   Montagna, Marco ^l   Radice, Paolo ^d,f   Palli, Domenico ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^f FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

^h NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

ⁱ UNIVERSITY OF PALERMO   (Italy)

^j UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^k CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^l VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

more..

Author keywords

BRCA1; BRCA2; Clinical pathologic features; Male breast cancer; Molecular subtypes

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BRCA GENE; BRCA2 GENE; BREAST CANCER; CANCER CLASSIFICATION; CANCER GRADING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; GENE MUTATION; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; MALE; MALE BREAST; MULTICENTER STUDY; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; TRIPLE NEGATIVE BREAST CANCER;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; DNA MUTATIONAL ANALYSIS; GENES, BRCA1; GENES, BRCA2; HUMANS; ITALY; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84863987646     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2062-0     Document Type: Article

References (22)

1. V Speirs AM Shaaban 2009 The rising incidence of male breast cancer Breast Cancer Res Treat 115 2 429 430 18478326 10.1007/s10549-008-0053-y
2. A Jemal R Siegel J Xu E Ward 2010 Cancer statistics CA Cancer J Clin 60 5 277 300 20610543 10.3322/caac.20073
3. WF Anderson I Jatoi J Tse PS Rosenberg 2010 Male breast cancer: a population-based comparison with female breast cancer J Clin Oncol 28 232 239 19996029 10.1200/JCO.2009.23.8162
4. WF Anderson MD Althuis LA Brinton SS Devesa 2004 Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 83 1 77 86 14997057 10.1023/B:BREA.0000010701.08825.2d
5. L Ottini P Rizzolo I Zanna M Falchetti G Masala K Ceccarelli V Vezzosi A Gulino G Giannini S Bianchi F Sera D Palli 2009 BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy Breast Cancer Res Treat 116 3 577 586 18819001 10.1007/s10549-008-0194-z
6. IS Fentiman A Fourquet GN Hortobagyi 2006 Male breast cancer Lancet 367 595 604 16488803 10.1016/S0140-6736(06)68226-3
7. AC Vargas JS Reis-Filho SR Lakhani 2011 Phenotype-genotype correlation in familial breast cancer J Mammary Gland Biol Neoplasia 16 1 27 40 21400086 10.1007/s10911-011-9204-6
8. E Honrado A Osorio J Palacios J Benitez 2006 Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations Oncogene 25 43 5837 5845 16998498 10.1038/sj.onc.1209875 1:CAS:528:DC%2BD28XhtVSgurjN
9. AL Bane JC Beck I Bleiweiss SS Buys E Catalano MB Daly G Giles AK Godwin H Hibshoosh JL Hopper EM John L Layfield T Longacre A Miron R Senie MC Southey DW West AS Whittemore H Wu IL Andrulis FP O'Malley 2007 BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays Am J Surg Pathol 31 1 121 128 17197928 10.1097/01.pas.0000213351.49767.0f
10. L Da Silva SR Lakhani 2010 Pathology of hereditary breast cancer Mod Pathol 23 Suppl 2 S46 S51 20436502 10.1038/modpathol.2010.37
11. Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O'Malley F, John EM, Janavicius R, Tihomirova L, Hansen TV, Nielsen FC, Osorio A, Stavropoulou A, Benítez J, Manoukian S, Peissel B, Barile M, Volorio S, Pasini B, Dolcetti R, Putignano AL, Ottini L, Radice P, Hamann U, Rashid MU, Hogervorst FB, Kriege M, van der Luijt RB; for HEBON, Peock S, Frost D, Evans DG, Brewer C, Walker L, Rogers MT, Side LE, Houghton C; for EMBRACE, Weaver J, Godwin AK, Schmutzler RK, Wappenschmidt B, Meindl A, Kast K, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Varon-Mateeva R, Schönbuchner I, Gevensleben H, Stoppa-Lyonnet D, Belotti M, Barjhoux L; for GEMO Study Collaborators, Isaacs C, Peshkin BN, Caldes T, de la Hoya M, Cañadas C, Heikkinen T, Heikkilä P, Aittomäki K, Blanco I, Lazaro C, Brunet J, Agnarsson BA, Arason A, Barkardottir RB, Dumont M, Simard J, Montagna M, Agata S, D'Andrea E, Yan M, Fox S; for kConFab Investigators, Rebbeck TR, Rubinstein W, Tung N, Garber JE, Wang X, Fredericksen Z, Pankratz VS, Lindor NM, Szabo C, Offit K, Sakr R, Gaudet MM, Singer CF, Tea MK, Rappaport C, Mai PL, Greene MH, Sokolenko A, Imyanitov E, Toland AE, Senter L, Sweet K, Thomassen M, Gerdes AM, Kruse T, Caligo M, Aretini P, Rantala J, von Wachenfeld A, Henriksson K; for SWE-BRCA Collaborators, Steele L, Neuhausen SL, Nussbaum R, Beattie M, Odunsi K, Sucheston L, Gayther SA, Nathanson K, Gross J, Walsh C, Karlan B, Chenevix-Trench G, Easton DF, Antoniou AC; for the Consortium of Investigators of Modifiers of BRCA1/2 (2012) Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the consortium of investigators of modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev 21(1):134-147
12. Y Ge N Sneige MA Eltorky Z Wang E Lin Y Gong M Guo 2009 Immunohistochemical characterization of subtypes of male breast carcinoma Breast Cancer Res 11 R28 19442295 10.1186/bcr2258
13. R Kornegoor AH Verschuur-Maes H Buerger MC Hogenes PC de Bruin JJ Oudejans P van der Groep B Hinrichs PJ van Diest 2012 Molecular subtyping of male breast cancer by immunohistochemistry Mod Pathol 25 3 398 404 22056953 10.1038/modpathol.2011.174 1:CAS:528:DC%2BC38Xjt1WqtLY%3D
14. AM Shaaban GR Ball RA Brannan G Cserni AD Benedetto J Dent L Fulford H Honarpisheh L Jordan JL Jones R Kanthan L Maraqa M Litwiniuk M Mottolese S Pollock E Provenzano PR Quinlan G Reall S Shousha M Stephens ET Verghese RA Walker AM Hanby V Speirs 2011 A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences Breast Cancer Res Treat 10.1007/s10549-011-1856-9
15. L Ottini G Masala C D'Amico B Mancini C Saieva G Aceto D Gestri V Vezzosi M Falchetti M De Marco M Paglierani A Cama S Bianchi R Mariani-Costantini D Palli 2003 BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy Cancer Res 63 342 347 12543786 1:CAS:528:DC%2BD3sXnt1KktA%3D%3D
16. S Bianchi D Palli M Falchetti C Saieva G Masala B Mancini R Lupi C Noviello J Omerovic M Paglierani V Vezzosi M Alimandi R Mariani-Costantini L Ottini 2006 ErbB-receptors expression and survival in breast carcinoma: a 15-year follow-up study J Cell Physiol 206 702 708 16245316 10.1002/jcp.20535 1:CAS:528:DC%2BD28XhsFWhtbk%3D
17. L Papi AL Putignano C Congregati I Zanna F Sera D Morrone M Falchetti MR Turco L Ottini D Palli M Genuardi 2009 Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany,Central Italy Breast Cancer Res Treat 117 3 497 504 18821011 10.1007/s10549-008-0190-3 1:CAS:528:DC%2BD1MXhtFegtbfJ
18. SH Giordano DS Cohen AU Buzdar G Perkins GN Hortobagyi 2004 Breast carcinoma in men: a population-based study Cancer 101 1 51 57 15221988 10.1002/cncr.20312
19. S Satram-Hoang A Ziogas H Anton-Culver 2007 Risk of second primary cancer in men with breast cancer Breast Cancer Res 9 1 R10 17254323 10.1186/bcr1643
20. UY Arslan B Oksüzoǧlu N Ozdemir S Aksoy N AlkIş A Gök MA Kaplan M Gümüş V Berk D Uncu M Baykara D Colak U Uyetürk I Türker A IşIkdoǧan 2011 Outcome of non-metastatic male breast cancer: 118 patients Med Oncol 10.1007/s12032-011- 9978-9
21. ZA Nahleh R Srikantiah M Safa AR Jazieh A Muhleman R Komrokji 2007 Male breast cancer in the veterans affairs population: a comparative analysis Cancer 109 8 1471 1477 17342768 10.1002/cncr.22589
22. Mitra AV, Bancroft EK, Barbachano Y, Page EC, Foster CS, Jameson C, Mitchell G, Lindeman GJ, Stapleton A, Suthers G, Evans DG, Cruger D, Blanco I, Mercer C, Kirk J, Maehle L, Hodgson S, Walker L, Izatt L, Douglas F, Tucker K, Dorkins H, Clowes V, Male A, Donaldson A, Brewer C, Doherty R, Bulman B, Osther PJ, Salinas M, Eccles D, Axcrona K, Jobson I, Newcombe B, Cybulski C, Rubinstein WS, Buys S, Townshend S, Friedman E, Domchek S, Ramon Y Cajal T, Spigelman A, Teo SH, Nicolai N, Aaronson N, Ardern-Jones A, Bangma C, Dearnaley D, Eyfjord J, Falconer A, Grönberg H, Hamdy F, Johannsson O, Khoo V, Kote-Jarai Z, Lilja H, Lubinski J, Melia J, Moynihan C, Peock S, Rennert G, Schröder F, Sibley P, Suri M, Wilson P, Bignon YJ, Strom S, Tischkowitz M, Liljegren A, Ilencikova D, Abele A, Kyriacou K, van Asperen C, Kiemeney L; IMPACT Study Collaborators, Easton DF, Eeles RA (2011) Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMCACT study. BJU Int 107(1):28-39